"
Saudi Consensus for Oral Semaglutide, the Recent Innovation in GLP-1 RAs Era; Consensus Report"
written by Ali Alromaih, Abdullah Alshamrani, Bandar Alharbi, Ibtissam Alharbi, Turki Alharbi, Samia Bokhari, Hussein Elbadawi, Mohammed Almehthel, Abdulghani Alsaeed, Khalid Alyahia, Fatimah Alhowyan, Marc Evans, Roopa Mehta, Emad Issak, Saud Alsifri,
published by
Journal of Diabetes Mellitus,
Vol.13 No.2, 2023
has been cited by the following article(s):
|
[1]
|
Budget impact of introducing oral semaglutide to the public healthcare benefit package in Saudi Arabia
Journal of Medical Economics,
2023
DOI:10.1080/13696998.2023.2277056
|
|
|
|